Intracranial Stenosis Stents Market Size Worth $1,620.02 Million By 2032 | CAGR: 7.50%

Intracranial Stenosis Stents Market Size Worth $1,620.02 Million By 2032 | CAGR: 7.50%

The global intracranial stenosis stents market size is expected to reach USD 1,620.02 million by 2032, according to a new study by Polaris Market Research. The report “Intracranial Stenosis Stents Market Share, Size, Trends, Industry Analysis Report, By Product (Self-expanding Stents, Embolization Coil Support Intracranial Stents, Venous Sinus Stents, Balloon-expanding), By End-use, By Region, And Segment Forecasts, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Stroke is indeed a significant cause of both mortality and morbidity globally. Large artery atherosclerosis is responsible for around 20% of all ischemic strokes among the different types of strokes. Approximately 50% of cases within this category are intracranial, meaning the blockage or narrowing of arteries occurs within the brain. Unfortunately, even with medical treatment, intracranial large artery atherosclerosis carries a relatively high recurrence rate. This highlights the need for effective interventions and management strategies to address this condition and reduce its impact on individuals' health.

In addition to large artery atherosclerosis, intracranial stenosis is a notable contributor to ischemic strokes. It accounts for approximately 10% of ischemic strokes in the U.S. and can be even more prevalent, reaching up to 50 percent in certain regions of Asia. The rising incidence of Intracranial Atherosclerotic Disease (ICAD) may be higher than reported, as current diagnostic methods may not detect symptomatic, non-stenotic atherosclerotic plaques. Autopsy analyses of stroke patients have revealed many such plaques. Interestingly, around 6% of these plaques were found to have superimposed thrombi, indicating a potential association with ischemic events.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:

Studies show differences in the prevalence of ICAD among various racial and ethnic groups. Hispanics, Africans, and Asians are more likely to have higher ICAD rates than other ethnic backgrounds. These differences may be due to various factors, including varying risk factor profiles, dietary habits, and genetics. For instance, African American patients have a higher prevalence of hypertension, hyperlipidemia, and diabetes mellitus, which are linked to this group's higher prevalence of ICAD. These risk factors contribute to the development and progression of atherosclerosis, leading to intracranial atherosclerotic plaques.

A research study published in the Radiological Society of North America examined 169 patients and found that 20 individuals (11.8%) experienced complications. Among these individuals, 10.5% suffered from strokes. Four patients had symptomatic intracranial hemorrhages (ICHs), and six had ischemic stroke. Unfortunately, two of these patients died due to complications. Additionally, two patients had asymptomatic ICHs, one experienced a transient ischemic attack, and another had an asymptomatic dissection. These findings demonstrate the occurrence of various complications associated with intracranial stenting procedures, including both symptomatic and asymptomatic events such as strokes and hemorrhages.

Intracranial Stenosis Stent Market Report Highlights

  • Self-expanding stents segment dominated the market, as they are more effective treatment option, with low complication rate
  • Hospitals segment garnered the largest share, as these surgeries are very complicated and requires cutting edge equipment
  • North America region dominated the global market with largest share in 2022, due to availability of well established and trained medical fraternity
  • The global key market players include Phenox, Medtronic, Acandis GmbH, MicroPort Scientific Corporation, MicroVention, CERENOVUS, Sino Medical Sciences Technology, Stryker, and Balt.

Polaris Market Research has segmented the intracranial stenosis stent market report based on product, end use, and region:

Intracranial Stenosis Stent, Product Outlook (Revenue - USD Million, 2023 - 2032)

  • Self-expanding Stents
  • Embolization Coil Support Intracranial Stents
  • Venous Sinus Stents
  • Balloon-expanding & Other Stents

Intracranial Stenosis Stent, End Use Channel Outlook (Revenue - USD Million, 2023 - 2032)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others       

Intracranial Stenosis Stent, Regional Outlook (Revenue - USD Million, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Intracranial Stenosis Stents Market Report Scope

Report Attributes


Market size value in 2024

USD 910.72 million

Revenue forecast in 2032

USD 1,620.02 million


7.50% from 2024 – 2032

Base year


Historical data

2019 – 2022

Forecast period

2024 – 2032

Quantitative units

Revenue in USD million/billion and CAGR from 2024 to 2032

Segments covered

By Product, By End Use, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa

Key companies

Phenox, Medtronic, Acandis GmbH, MicroPort Scientific Corporation, MicroVention, CERENOVUS, Sino Medical Sciences Technology, Stryker, and Balt.

For Specific Research Requirements

Request Customized Report